| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7305effc496dec13622f0c922f5578db |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G69-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G69-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G69-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34 |
| filingDate |
2018-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1dd95c1e7b709644ae071a4f74ee094
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_acf5f069b132ad712b5520f8d2cc4a28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76a1a308bcae5c228f17713d2c97af7a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f32ba3fdd7f03b0f15a39b4018f4a7a3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c84bafbe5fd28db59f6266b0fab0a77 |
| publicationDate |
2020-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2018380901-A2 |
| titleOfInvention |
Compositions in the form of an injectable aqueous solution comprising amylin, an amylin receptor agonist or an amylin analog and a copolyamino acid |
| abstract |
The invention relates to a composition in the form of an injectable aqueous solution having a pH between 6.0 and 8.0 and comprising at least: a) amylin, an amylin receptor agonist or an amylin analog; b) a copolyamino acid bearing carboxylate charges and hydrophobic radicals Hy, said copolyamino acid being formed by aspartic glutamic units and said hydrophobic radicals Hy having formula X, characterized in that the composition comprises no basal insulin having an isoelectric point pi between 5.8 and 8.5. The invention further relates to a composition characterized in that it further comprises a prandial insulin. |
| priorityDate |
2017-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |